Skip to main content
OpenTrials

Clinical trial condition

Type 2 Diabetes Mellitus

Explore clinical trials studying Type 2 Diabetes Mellitus. Study availability and eligibility vary by location and protocol.

1,509 public trials 41 recruiting studies
Refine in advanced search Browse all conditions

Type 2 Diabetes Mellitus trial results

Completed

Safety and Efficacy of Bexagliflozin Compared to Glimepiride as Add-on Therapy to Metformin in Type 2 Diabetes Subjects

NCT02769481

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Huntington Park, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site San Carlos, California, United States
View all 45 locations
View Trial Details
Completed

Efficacy and Safety of Sotagliflozin Versus Glimepiride and Placebo in Participants With Type 2 Diabetes Mellitus That Are Taking Metformin Monotherapy

NCT03332771

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Investigational Site Number 8407040 Birmingham, Alabama, United States
  • Investigational Site Number 8407048 Birmingham, Alabama, United States
  • Investigational Site Number 8407035 Little Rock, Arkansas, United States
  • Investigational Site Number 8407051 Anaheim, California, United States
View all 142 locations
View Trial Details
Completed

Efficacy and Safety of Sotagliflozin Versus Placebo in Patients With Type 2 Diabetes Mellitus on Background of Metformin

NCT02926950

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Investigational Site Number 8402003 Birmingham, Alabama, United States
  • Investigational Site Number 8402017 Birmingham, Alabama, United States
  • Investigational Site Number 8402052 Phoenix, Arizona, United States
  • Investigational Site Number 8402056 Canoga Park, California, United States
View all 93 locations
View Trial Details
Completed

Efficacy and Safety of Sotagliflozin Versus Placebo in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control While Taking Insulin Alone or With Other Oral Antidiabetic Agents

NCT03285594

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Investigational Site Number 8406028 Mesa, Arizona, United States
  • Investigational Site Number 8406013 Phoenix, Arizona, United States
  • Investigational Site Number 8406020 Phoenix, Arizona, United States
  • Investigational Site Number 8406006 Huntington Park, California, United States
View all 106 locations
View Trial Details
Completed

Efficacy and Safety of Sotagliflozin Versus Placebo and Empagliflozin in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control While Taking a DPP4 Inhibitor Alone or With Metformin

NCT03351478

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Investigational Site Number 8408035 Birmingham, Alabama, United States
  • Investigational Site Number 8408028 Sheffield, Alabama, United States
  • Investigational Site Number 8408047 Hawaiian Gardens, California, United States
  • Investigational Site Number 8408031 Spring Valley, California, United States
View all 160 locations
View Trial Details

Related conditions